Orthocell Limited (ASX:OCC)
Australia · Delayed Price · Currency is AUD 0.9500
+0.0700 (7.95%)
Jan 30, 2026, 12:58 PM AEST
Orthocell Market Cap
Orthocell has a market cap or net worth of 238.75 million as of January 29, 2026. Its market cap has decreased by -27.56% in one year.
Market Cap
238.75M
Enterprise Value
210.71M
Revenue
7.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.95
Market Cap Chart
Since August 12, 2014, Orthocell's market cap has increased from 29.70M to 238.75M, an increase of 703.88%. That is a compound annual growth rate of 19.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 238.75M | -18.89% |
| Dec 31, 2025 | 294.37M | -9.37% |
| Dec 31, 2024 | 324.80M | 297.55% |
| Dec 29, 2023 | 81.70M | 1.05% |
| Dec 30, 2022 | 80.85M | -19.58% |
| Dec 31, 2021 | 100.54M | 20.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Clinuvel Pharmaceuticals | 611.45M |
| Racura Oncology | 482.40M |
| Dimerix | 315.21M |
| Botanix Pharmaceuticals | 246.26M |
| Tetratherix | 192.91M |
| Recce Pharmaceuticals | 189.42M |
| Actinogen Medical | 159.59M |
| Starpharma Holdings | 146.97M |